Logos Global Management LP Applied Therapeutics Inc. Transaction History

Logos Global Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$4.04 - $6.37 $3.03 Million - $4.78 Million	-750,000 Reduced 55.56%	600,000 $2.8 Million
Q1 2024 May 15, 2024	SELL	$2.25 - $7.4 $697,500 - $2.29 Million	-310,000 Reduced 18.67%	1,350,000 $9.18 Million
Q4 2023 Feb 14, 2024	BUY	$1.84 - $3.35 $3.05 Million - $5.56 Million	1,660,000 New	1,660,000 $5.56 Million
Q3 2020 Nov 16, 2020	SELL	$19.43 - $35.36 $244,818 - $445,536	-12,600 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$29.41 - $51.23 $370,566 - $645,498	12,600 New	12,600 $455,000

140

112M

1.68M

1.91M

Ticker APLT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,020,700
Market Cap $42.3M
Description
Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...

Get notified when there are updates to the investment portfolio of Logos Global Management LP, based on Form 13F filings with the SEC.

Stay updated on Logos Global Management LP with notifications on news.